biomedicina slovenica

pr=Colleoni : 10

  1. Gennari Alessandra; Sun Z.; Hasler-Strub U.; Colleoni Marco; Moos Roger von; Cortes Jorge; Walshe J.; Ribi K.; Bernhard Jürg; Borštnar Simona
    A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer
    2018 ►
  2. Thurlimann Beat; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Colleoni Marco; Collins John; Forbes John F; Castiglione-Gertsch Monica; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
    2009 ►
  3. Colleoni M; Li SZ; Gelber Richard D; Coates Alan S; Castiglione-Gertsch M; Price Karen; Lindtner Jurij; Rudenstam Carl-Magnus; Crivellari Diana; Collins Joseph; Pagani Olivia; Simoncini E.; Thürlimann Beat; Murray Elizabeth; Forbes John Alexander; Eržen Darja; Holmberg Stig B.; Veronesi A.; Goldhirsch Aron; Plesničar Andrej; Majdič Elga; Štabuc Borut; Golouh Rastko; Lamovec Janez; Jančar Janez; Vrhovec Ivan; Kramberger Marta; Novak Janez; Naglas M; Senčar Mojca; Červek Jožica; Šebek Slava; Cerar Olga; Čufer Tanja
    Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer
    2005 ►
  4. Colleoni M; Litman HJ; Castiglione-Gertsch M; Sauerbrei W; Gelber RD; Bonetti M; Coates AS; Schumacher M; Bastert G; Lindtner J
    Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
    2002 ►
  5. Colleoni M; Zahrieh D; Nole F; Gelber RD; Castiglione-Holmberg M; Price KN; Thurlimann B; Lindtner J; Forbes J; Collins J
    Is medial breast cancer without axillary node involvement really node-negative?
    2002 ►
  6. Colleoni Marco; Gelber Shari; Coates Alan S; Castiglione-Gertsch Monica; Gelber Richard D; Price Karen; Rudenstam Carl-Magnus; Lindtner Jurij; Collins John; Thuerlimann Beat
    Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
    2001 ►
  7. Colleoni Marco; Smith Heather; Castiglione-Gertsch Monica; Gelber Richard D; Sauerbrei Willi; Coates Alan S; Schumacher Martin; Bonetti Marco; Bastert Gunter; Lindtner Jurij
    Duration of adjuvant chemotherapy: a joint analysis of two randomized trails investigating 3 versus 6 courses of cyclophosphamide methotrexate and 5-fluorouracil (CMF) without endocrine treatment
    2000 ►
  8. Colleoni Marco; O'Neill Anne; Goldhirsch Aron; Gelber Richard D; Bonetti Marco; Thuerlimann Beat; Price Karen N; Castiglione-Gertsch Monica; Coates Alan S; Lindtner Jurij
    Identifying breast cancer patients at high risk for bone metastases
    2000 ►
  9. Colleoni Marco; Bonetti Marco; Coates Alan S; Castiglione-Gertsch Monica; Gelber Richard D; Price Karen; Rudenstam Carl-Magnus; Lindtner Jurij; Collins John; Thuerlimann Beat
    Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors
    2000 ►
  10. Colleoni M; Price K; Gelber RD; Castiglione-Gertsch M; Rudenstam CM; Coates A; Thuerlimann B; Lindtner J; Collins J; Goldhirsch A
    Dose-response effect of adjuvant cyclophosphamide, methotrexate, fluorouracil in node-positive breast cancer
    1998 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics